Full Text View
Tabular View
No Study Results Posted
Related Studies
"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
This study has been completed.
Study NCT00201994   Information provided by Otsuka Pharmaceutical Development & Commercialization, Inc.
First Received: September 13, 2005   Last Updated: September 2, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyponatremia
Water Intoxication
Inappropriate ADH Syndrome
Water-Electrolyte Imbalance
Additional conditions recognized in this trial
Poisoning
Syndrome
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Disease
Disorders of Environmental Origin
Endocrine System Diseases
Hypothalamic Diseases
Metabolic Diseases
Nervous System Diseases
Pathologic Processes
Pituitary Diseases
Interventions listed in this trial
Tolvaptan
Sponsors listed in this trial
Otsuka Pharmaceutical Development &Commercialization, Inc.
Otsuka Pharmaceutical Co., Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services